v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Jun. 30, 2026
Equity [Abstract]  
SCHEDULE OF FAIR VALUE OF EACH OPTION GRANTED

For the three months ended June 30, 2026, the fair value of each option granted was estimated using the assumption and/or factors in the Black-Scholes Model as follows:

 

Exercise price  $0.56 
Expected dividend yield   0%
Risk free interest rate   4.26%
Expected life in years   6.02 
Expected volatility   159%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Stock Options               
Outstanding March 31, 2026   134,397   $3.72    4.55 
Granted   20,426    0.56    10.00 
Expired   (20,906)   3.72    - 
Exercised   -    -    - 
Outstanding June 30, 2026   133,917   $3.18    5.65 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of June 30, 2026, and changes during the three months ended June 30, 2026 is presented below:

 

Nonvested Options  Options  

Weighted- Average

Exercise Price

 
Nonvested at March 31, 2026   17,133   $2.08 
Granted   20,426    0.56 
Vested   (5,451)   2.23 
Forfeited   -    - 
Nonvested at June 30, 2026   32,108   $1.79 
SUMMARY OF WARRANT

A summary of warrant issuances are as follows:

 

   Number  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Life

 
Warrants               
Outstanding March 31, 2026   3,243,549   $267.57    0.17 
Granted   -    -    - 
Expired   (3,169,043)   273.79    - 
Exercised   -    -    - 
Outstanding June 30, 2026   74,506   $0.84    3.48